 |
 |
 |
 |
 |
 |
Goff DC, Lamberti JS, Leon AC, Green MF, Miller AL, Patel J, Manschreck T, Freudenreich O, Johnson SA.
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology.
2008 Feb
;
33(3):465-72.
Pubmed Abstract
|
 |
|